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ABBREVIATIONS
AIS Arterial ischemic stroke
SIPS Seizures in Pediatric Stroke
AIM To determine epilepsy risk factors after pediatric stroke.
METHOD A cohort of children with arterial ischemic stroke (birth–18y) was enrolled at 21
centers and followed for 1 year. Acute seizures (≤7d after stroke) and active epilepsy (at least
one unprovoked remote seizure plus maintenance anticonvulsant at 1y) were identified.
Predictors were determined using logistic regression.
RESULTS Among 114 patients (28 neonates and 86 children) enrolled, 26 neonates (93%) and
32 children (37%) had an acute seizure. Acute seizures lasted longer than 5 minutes in 23
patients (40%) and were frequently recurrent: 33 (57%) had 2 to 10 seizures and 11 (19%) had
more than 10. Among 109 patients with 1-year follow-up, 11 (10%) had active epilepsy. For
each year younger, active epilepsy was 20% more likely (odds ratio [OR] 0.8, 95% confidence
interval [CI] 0.6–0.99, p=0.041). Prolonged or recurrent acute seizures also increased epilepsy
risk. Each additional 10 minutes of the longest acute seizure increased epilepsy risk fivefold
(OR 4.7, 95% CI 1.7–13). Patients with more than 10 acute seizures had a 30-fold increased
epilepsy risk (OR 30, 95% CI 2.9–305).
INTERPRETATION Pediatric stroke survivors, especially younger children, have a high risk of
epilepsy 1 year after stroke. Prolonged or recurrent acute seizures increase epilepsy risk in a
dose-dependent manner.
Arterial ischemic stroke (AIS) is a leading cause of child-
hood brain injury. Many survivors suffer from permanent
disability and epilepsy, although a subset recover without
significant deficits. One of the critical differences of pedi-
atric stroke compared with stroke in adults is that chil-
dren frequently experience acute symptomatic seizures.
Only 2% to 4% of adults with stroke have an acute sei-
zure.1 In contrast, an estimated 75% to 90% of neonates
and 20% to 30% of children with AIS have acute
seizures.2–7 Convulsions at stroke presentation are more
likely in young children.8,9 Although determinants of epi-
lepsy after pediatric AIS are poorly understood, emerging
data suggest early seizures may be associated.6,10–12
Therefore, the high incidence of acute seizures after pedi-
atric AIS is worrisome. However, we know little about
the characteristics of children who have acute seizures, or
the mechanisms by which acute seizures are associated
with epilepsy.
Large, prospective studies of neonates and children are
critical to understand which patients are at greatest risk of
epilepsy, and how acute seizures or other factors might
influence that risk. Moreover, accurate prediction of epi-
lepsy risk will allow providers to appropriately counsel
patients and families and guide future research. We aimed
to prospectively determine incidence rates and risk factors
of acute seizures and epilepsy after pediatric AIS. We
hypothesized that age at the time of a stroke is an impor-
tant determinant both of acute symptomatic seizures and
of later development of post-stroke epilepsy. Further, we
hypothesized that the duration and frequency of acute sei-
zures during the first week after stroke modify epilepsy
risk.
METHOD
Seizures in Pediatric Stroke (SIPS) investigators at 21 sites
(Appendix S1, online supporting information) enrolled
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newborns who were born at or after 37 weeks’ gestation
and children no older than 18 years within 14 days of
stroke onset from March 2011 to August 2012 using the
infrastructure of the International Pediatric Stroke Study, a
multicenter pediatric stroke consortium. All sites obtained
approval from their local institutional review board and
written informed consent from guardians. For all partici-
pants, a child neurologist (GD or CKF) adjudicated brain
imaging (computed tomography or magnetic resonance
imaging) to confirm AIS with supplemental neuroradiolo-
gist review as needed. Inclusion criteria were: (1) acute
focal neurological deficit or seizure consistent with stroke;
and (2) arterial infarct on computed tomography or mag-
netic resonance imaging consistent with clinical symptom
location and timing.
Local site investigators determined acute seizures on a
clinical basis or by electroencephalography (EEG) per-
formed for clinical indications, documented the number of
acute seizures as an ordinal categorical variable (single, 2–
10 seizures, or >10 seizures), and the duration of the long-
est acute seizure in minutes. Infarct characteristics were
collected from clinical reports. At hospital discharge, guar-
dians were given seizure diaries with instructions to docu-
ment remote seizures. Longitudinal follow-up data
including anticonvulsant use and characteristics of seizures
after hospital discharge were obtained by review of health
records, standardized telephone or in-person parental ques-
tionnaires at 3 months, and in-person investigator visit
1 year after stroke. All data were abstracted onto standard-
ized case record forms.
Definitions
Neonatal stroke was defined as a stroke presenting from
birth to 28 days old; childhood stroke was defined as a
stroke presenting at age 29 days to 18 years old. Acute sei-
zures were defined as a seizure at stroke onset or within
the subsequent 7 days.13 Remote seizure was defined as a
seizure more than 7 days after stroke and excluded seizures
provoked by fever, transient ischemic attack, or stroke
recurrence.13 Active epilepsy was defined as treatment with
a maintenance anticonvulsant at the 1-year follow-up in a
child who had at least one remote seizure.14
Statistical analysis
Statistical analyses were performed using Stata 14 (Stata-
Corp, College Station, TX, USA). Summary statistics were
used to describe the cohort demographics and baseline
clinical characteristics. Proportions were compared by v2
testing. We described the onset time of acute seizures in
children but not in neonates, because the exact time of
stroke onset for neonates is generally not known. Acute
seizure predictors were determined by logistic regression.
We first estimated the probability of acute seizure by age
in a linear model. Because the association of acute seizures
and age had evidence of nonlinearity, we then depicted the
association graphically as a cubic spline to allow variation
across age. We considered variables with marginal
outcome associations significant at the p<0.1 for inclusion
in multivariable analysis of acute seizure predictors. In the
final model, we included age in years but not neonatal
stroke to avoid overfitting. Survival analysis methods were
used to estimate remote seizure incidence rates. Time at
risk began 7 days after stroke; in neonates, stroke onset
was assumed to be on the day of birth. Patients were right-
censored at the last observed seizure-free date. We present
Kaplan–Meier plots stratified by acute seizure (yes/no) and
acute seizure frequency. Predictors of active epilepsy at 1-
year follow-up were determined by logistic regression. We
performed a test for trend to determine whether acute sei-
zure frequency (categorized as none, single, 2–10, or more
than 10 seizures) was associated with higher epilepsy risk.
For sensitivity analyses, we repeated predictor testing,
applying the assumption that patients with an acute seizure
but incomplete data for duration or frequency had only
brief (30s) or a single acute seizure to provide conservative
estimates. We did not report a multivariable model for
epilepsy predictors because of the limited number of
outcomes.
RESULTS
We enrolled 114 patients (73% of the eligible sample;
28 neonates and 86 children) (Fig. 1). Median age of
neonates at the time of AIS symptom onset was day of
life 0 (range 0–20d). Median age for children was 6 years
1 month (interquartile range 1y 5mo–12y). Baseline
demographics and clinical characteristics of the partici-
pants are shown in Table I. An acute seizure was identi-
fied in 26 (93%) neonates and 32 (37%) children.
Neonates were more likely to have recurrent acute sei-
zures compared with older children (88% vs 66% of
those with an acute seizure, p=0.043), but recurrent acute
seizures were common overall. Acute seizures were often
prolonged (Fig. 2a). Among the 32 children with an
acute seizure, 12 (38%) were seizing upon arrival to the
emergency department. Onset of the first seizure was
delayed by at least 8 hours after stroke presentation in
another 12 (38%). Seizures were classified as focal motor
in 21 (81%) neonates, with the remainder classified as
generalized. Among children, the seizures were classified
as focal motor (n=23; 72%), complex partial (n=5; 16%),
simple partial (n=3; 9%), and bilateral convulsive (n=2;
6%). At the end of the stroke hospitalization, 23 neo-
nates (82% of neonates in the cohort) and 25 children
(29% of all children in the cohort) were discharged on
an anticonvulsant medication, including two neonates
and three children who did not have an acute seizure.
What this paper adds
• Younger children are at higher risk of acute seizures and epilepsy after
stroke.
• One year after pediatric stroke, 10% of survivors are treated for epilepsy.
• Each 10-minute increase in acute seizure duration increases epilepsy risk
fivefold.
• Children with more than 10 acute seizures after stroke have a 30-fold
increased epilepsy risk.
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On univariate analyses, younger age and stroke involving
the middle cerebral artery territory predicted acute seizures
(Table II). Overall, acute seizures were 20% more likely
(odds ratio [OR] 0.8, 95% confidence interval [CI] 0.7–0.9,
p<0.001) for each year of age below age 18 at the time of
AIS. However, the risk was nonlinear, with greater proba-
bility of acute seizures under 4 years of age (Fig. 2b). The
magnitude of risk and shape of the curve were similar
when neonates were excluded from the model, except that
95% CIs were wider at the youngest ages (Fig. S1, online
supporting information). We did not find an association
between acute seizures and hemorrhagic conversion or cor-
tical infarct location. In a multivariable model including
age in years, the presence of an arteriopathy, and middle
cerebral artery territory infarct, estimates of association
were younger age (OR 0.8, 95% CI 0.7–0.9, p<0.001),
arteriopathy (OR 0.3, 95% CI 0.1–0.8, p=0.022), and mid-
dle cerebral artery territory infarct (OR 3.3, 95% CI 1.2–
9.1, p=0.021).
Follow-up was available for 109 children (three were
deceased, two were lost to follow-up) at a median of
12.3 months (interquartile range 11.6–13) after stroke. All
13 of the children with a remote seizure had been dis-
charged on an anticonvulsant after their stroke hospitaliza-
tion. Children with an acute seizure had a 2% (95% CI
1.1–3.4%) average monthly incidence rate of a first remote
seizure with 18% (95% CI 10–31%) cumulative incidence
at 1 year after stroke (Fig. 2c). At 1 year, 11 patients
(10%, 95% CI 4–16%) had active epilepsy, including three
with neonatal stroke (11%) and eight with childhood
stroke (10%; p=0.854 for difference between neonates and
children). Epilepsy severity varied. Over the year, seven of
the children with epilepsy had more than one remote sei-
zure and three reported at least 100 seizures (Table SI,
online supporting information). Eight of the children had
been treated with multiple anticonvulsants, and four of the
children had ongoing treatment with concurrent anticon-
vulsants.
For each year younger than 18 at the time of stroke,
active epilepsy risk increased 20% (OR 0.8, 95% CI 0.6–
0.99, p=0.041); this relationship was similar when neonatal
strokes were excluded (OR 0.7, 95% CI 0.5–0.96,
p=0.027). Acute systemic illness and acute seizures were
also risk factors for active epilepsy (Table II). Greater
duration or frequency of acute seizures elevated epilepsy
risk in a dose-dependent manner. Each additional 10-min-
ute duration of the longest acute seizure increased active
epilepsy risk fivefold (OR 4.7, 95% CI 1.7–13.1). Children
with a higher number of recurrent acute seizures had
greater probability of a first remote seizure (Fig. 2d).
Patients with more than 10 acute seizures had 30-fold
increased risk of active epilepsy at 1 year compared with
patients without an acute seizure (Table II). EEG charac-
teristics were only available for the subset of children in
which EEG was clinically performed (n=51). In this subset,
abnormal slowing on the acute EEG was associated with
10-fold increased risk of active epilepsy (OR 9.7, 95% CI
1.1–84, p=0.036) at 1 year, but we did not find an associa-
tion with the presence of epileptiform discharges (OR 2.9,
95% CI 0.7–13, p=0.172). In sensitivity analyses, acute sei-
zure duration was unknown in 10 out of 109 (8%); four
patients had at least one acute seizure with an unknown
Patients identified with potential AIS
n=166
Patients enrolled
Acute seizures
Remote seizures Remote seizuresNo remote No remote
seizures seizures(>7d) (>7d)
n=1 n=52n=44n=12
n=10 n=2
n=10 n=46 n=1 n=52
Active epilepsy Active epilepsyNo active epilepsy No active epilepsy
No acute seizures
(≤7d of strokes)(≤7d of stroke)
n=58 n=56
Deceased, n=2
Lost to follow-up, n=1
Deceased, n=1
No consent, n=43
Stroke not confirmed, n=9
Lost to follow-up, n=1
n=114 (28 neonates, 86 children)
Figure 1: Flow diagram of pediatric stroke cohort demonstrating seizures and epilepsy during the first year after stroke. The final cohort included 114
participants. Among these, 109 completed 1-year follow-up for a measurement of active epilepsy. AIS, arterial ischemic stroke.
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number of additional seizures. Assuming that patients with
unknown acute seizure duration had brief (30s) seizures,
each additional 10 minutes in longest acute seizure dura-
tion still increased active epilepsy risk (OR 3.5, 95% CI
1.4–8.8, p=0.009). Assuming that the patients with an acute
seizure but unknown frequency had only a single seizure
did not substantially change the estimate or magnitude of
the association of seizure frequency and active epilepsy
(OR 30, 95% CI 2.9–305, p=0.004 for children with more
than 10 acute seizures compared with those with no acute
seizures).
DISCUSSION
In this prospective study, we demonstrated that a signifi-
cant proportion of pediatric stroke survivors later develop
epilepsy. Among children who had an acute symptomatic
seizure, the incidence rate of a first remote seizure is about
2% each month during the year after stroke. By 1 year
after stroke, 10% of all neonates and children were on a
maintenance medication for active epilepsy. Nearly half of
the children in our cohort had been discharged from the
stroke hospitalization on maintenance anticonvulsants.
Ongoing anticonvulsant treatment during the first year
after stroke may have prevented a first remote seizure,
resulting in an underestimation of the natural history of
epilepsy development. Importantly, we did not find a level-
ing off of the remote seizure incidence rate by 1 year, and
speculate that the risk probably persists well beyond the
first year, resulting in higher incidence of post-stroke epi-
lepsy over time.
The incidence rate of epilepsy in our study is higher
than that reported among children in the population-based
Kaiser Pediatric Stroke Study, in which 3.6% of children
developed active epilepsy annually, with a cumulative inci-
dence of 13% at 5 years.6 Our higher incidence rates may
be explained by age differences between the stroke cohorts;
our cohort included neonates with stroke. Among neonates
in the Kaiser Pediatric Stroke Study, the cumulative inci-
dence of an unprovoked remote seizure was similar to our
cohort, at 20% by 1 year of age.10 Another reason for our
higher incidence rate could be that our cohort, enrolled at
pediatric stroke centers that are generally regional tertiary
care facilities, may have preferentially included children
with more severe strokes or greater medical illness, who
were then more likely to go on to develop epilepsy.
Finally, the Kaiser Pediatric Stroke Study was dependent
on electronic database searches to identify patients with
epilepsy, and may have underestimated epilepsy incidence
rates.
We found that younger age and middle cerebral artery
territory strokes predict acute seizures. The incidence of
acute seizures after neonatal AIS should be considered with
detection bias in mind because very young infants may not
show other clinical signs of stroke. In neonates with AIS,
an estimated 80% of seizures identified on continuous
EEG may be clinically unsuspected.15 Systematic continu-
ous EEG monitoring in all patients would be a better way
to identify and quantify all seizures but was beyond the
scope of our study. Yet, the magnitude and shape of the
curve of acute seizure probabilities does not change for
children when neonates were excluded, suggesting that this
potential bias does not account for the observed association
with young age. Younger age also predicts epilepsy at
1 year after stroke; this was unchanged when neonates
were excluded.
Few previous studies have directly measured epilepsy
after pediatric AIS across age groups. Younger children
may have had different infarct characteristics than older
children, which could influence epileptogenesis and the
age-related epilepsy risk. Alternatively, characteristics of
the immature brain that favor excitatory neurotransmitter
systems could account for both a vulnerability to acute sei-
zures and the transformation of a normal neuronal network
into a hyperexcitable one after an ischemic infarct.16,17 A
third possibility is that acute seizures in the setting of
Table I: Demographics and characteristics of 114 neonates and children
with arterial ischemic stroke
Neonates
(n=28)
Children
(n=86)
n (%) n (%)
Demographics
Male 15 (54) 51 (59)
North American 20 (71) 60 (70)
Hispanic parent 6 (21) 15 (17)
Stroke risk factors
Arteriopathy 1 (4) 33 (38)
Cardiac disease 7 (26) 22 (26)
Acute illness 6 (22) 21 (24)
Underlying chronic disease 2 (7) 24 (28)
Head trauma at time of stroke 0 (0) 7 (8)
No risk factor identified 14 (50) 15 (17)
Clinical characteristics
Prolonged acute seizure (≥5min) 8 (29) 11 (13)
History of seizure before stroke 0 (0) 5 (6)
Family history of epilepsy 1 (4) 0 (0)
Discharged home 24 (86) 70 (81)
Infarct description
MCA territory stroke 23 (82) 53 (62)
ACA territory stroke 2 (7) 12 (14)
PCA territory stroke 3 (11) 18 (21)
Cortical stroke location 10 (36) 15 (17)
Multifocal infarcts 8 (29) 29 (34)
Any hemorrhage 4 (14) 3 (3)
EEG done 27 (96) 35 (41)
Routine EEG (<30min) 10 (36) 14 (16)
Prolonged EEG (30min–2h) 8 (29) 13 (15)
Continuous EEG (>2h) 9 (32) 7 (8)
Acute seizure 26 (93) 32 (37)
Clinical seizure 19 (69) 26 (30)
Electrographic seizure 8 (29) 3 (3)
Electroclinical seizure 10 (36) 4 (5)
Seizure frequency
None 2 (7) 54 (63)
Single seizure 3 (11) 7 (8)
2–10 seizures 18 (64) 15 (17)
>10 seizures 5 (18) 6 (7)
Unknown frequency 0 (0) 4 (5)
Except for seizure frequency, categories were not mutually exclu-
sive, so do not sum to 100%. MCA, middle cerebral artery; ACA,
anterior cerebral artery; PCA, posterior cerebral artery; EEG, elec-
troencephalography.
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ischemia have an epileptogenic effect.18 Acute post-stroke
seizures were associated with epilepsy in our study and the
Kaiser Pediatric Stroke Study.6 Building on this associa-
tion, we found that epilepsy risk appears to increase in a
dose-related manner with an increasing number and dura-
tion of acute seizures. Children with more than 10 acute
seizures had a 30-fold increased epilepsy risk compared
with children who did not have an acute seizure.
Could acute seizures, observed more frequently in
younger children, explain the age-related epilepsy risk? A
high burden of acute seizures could potentially contribute
to epileptogenesis directly by inducing neurobiological
changes or indirectly by increasing metabolic demand in
poorly perfused brain and worsening secondary injury.
Current pediatric stroke guidelines do not recommend
continuous EEG monitoring or routine prophylactic
administration of antiepileptic medications after AIS before
acute seizures.19 Although acute seizures after pediatric
AIS might be preventable, in practice anticonvulsants are
typically only started after a seizure occurs. The most
appropriate time for starting anticonvulsant treatment and
the duration of treatment after acutely provoked seizures
subside, especially in neonates and younger children,
remain open questions. However, given the possibility that
prolonged or recurrent acute seizures are detrimental, our
data suggest an important theoretical opportunity for inter-
vention. A significant proportion of children did not seize
at stroke onset, suggesting a window of time to start an
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Figure 2: Acute and remote seizure characteristics and predictors after pediatric arterial ischemic stroke. (a) Durations of the longest acute seizure
(≤7d after stroke) after arterial ischemic stroke. (b) Younger age predicted acute seizures (black line, estimated probability of acute seizure by age;
shading, 95% confidence intervals [CI]); model includes neonates and children (all participants from birth to18y at the time of stroke). (c) Children with
an acute post-stroke seizure had a 2% (95% CI 1.1–3.4%) average monthly incidence rate of a first remote seizure and 18% (95% CI 10–31%) cumulative
incidence at 1 year after stroke. (d) Recurrent acute seizures were associated with increasing remote seizure risk. Reference group: patients with no
acute seizures; single acute seizure: hazard ratio 5 (95% CI 0.3–84, p=0.2); 2–10 acute seizures: hazard ratio 10 (95% CI 1.2–85, p=0.03); >10 acute sei-
zures: hazard ratio 26 (95% CI 2.9–230, p=0.004).
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early anticonvulsant. Further, most patients with an acute
seizure in our cohort went on to have multiple seizures
during the first week. Perhaps after stroke, epilepsy risk
could be modified through more aggressive acute seizure
management or early detection with continuous EEG
monitoring, but further research is required to determine
whether this is possible.
Our study had limitations. First, the timing of onset, fre-
quency, and duration of acute seizures were classified at the
judgment of the site investigator using all available clinical
and EEG data. Some patients may have had clinical or sub-
clinical seizures that were not identified, resulting in an
underestimation of acute seizure frequency or duration.
Misclassification of exposure is generally thought to result
in bias towards the null, so the strength of the association of
epilepsy risk with acute seizure presence, frequency, and
duration might be underestimated. Further, the estimated
risks of epilepsy associated with acute seizure frequency
were limited in precision, as reflected by large confidence
intervals. Second, remote seizures could have been related
to factors other than stroke in our cohort, such as head
trauma or underlying neurodevelopmental disorders. How-
ever, only 6% of the patients had head trauma at the time of
the AIS and none of these had active epilepsy at 1 year after
stroke. While 5% of the cohort had a history of seizure
before stroke, none of these children met our definition of
active epilepsy at 1 year. Finally, the cohort was not popula-
tion-based or a consecutively enrolled sample. Our estimates
of acute seizure probability could have been skewed if inves-
tigators preferentially enrolled patients either with or with-
out acute seizures.
Our study highlights that children have an increased and
age-related propensity for stroke-related seizures compared
with adults. Approximately one in five school-age children
has an acute seizure related to AIS, and this proportion is
even higher in younger children. Pediatric stroke survivors
have a significant risk of developing epilepsy, particularly if
they have experienced prolonged or multiple acute sei-
zures. Young children and those with middle cerebral
artery territory infarcts are important at-risk groups who
could be targeted for closer EEG monitoring and rapid
seizure management. Because acute seizures after stroke
are a potentially modifiable risk factor, future studies
should evaluate whether prevention of recurrent seizures
with anticonvulsants can reduce the risk of later epilepsy in
this vulnerable population.
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Table II: After pediatric arterial ischemic stroke (n=114), unadjusted odds ratios and 95% confidence intervals (CI) for clinical factors associated with
acute seizures (≤7d after stroke) and epilepsy at 1y (n=109 with 1y follow-up)
Acute seizures (n=58) Epilepsy (n=11)
OR (CI) p value OR (CI) p value
Demographics
Male 0.8 (0.4–1.7) 0.549 1.4 (0.4–5.2) 0.571
North American 0.6 (0.3–1.4) 0.270 1.1 (0.3–4.5) 0.857
Hispanic parent 0.9 (0.3–2.2) 0.741 1.0 (0.2–5.0) 0.976
Neonatal stroke 21.9 (4.9–98.6) <0.001 1.1 (0.3–4.6) 0.854
Age at stroke (y)a 0.8 (0.7–0.9) <0.001 0.7 (0.5–0.96) 0.027
Stroke risk factors
Cardiac disease 1.6 (0.7–3.7) 0.309 0.6 (0.1–3.2) 0.619
Arteriopathy 0.2 (0.1–0.6) 0.001 0.9 (0.2–3.6) 0.840
Acute illness 2.0 (0.8–4.8) 0.139 4.9 (1.2–17.6) 0.016
Underlying chronic disease 0.7 (0.3–1.6) 0.336 0.7 (0.1–3.5) 0.722
Head trauma 0.4 (0.1–2.0) 0.240 n/a
Infarct description
MCA territory 2.8 (1.2–6.3) 0.013 1.4 (0.3–5.4) 0.654
ACA territory 0.7 (0.2–2.1) 0.523 1.6 (0.3–8.3) 0.589
PCA territory 0.7 (0.3–1.8) 0.417 0.9 (0.2–4.6) 0.911
Cortical location 1.3 (0.5–3.2) 0.563 2.3 (0.6–9.0) 0.208
Multifocal 1.2 (0.6–2.6) 0.638 2.1 (0.6–7.4) 0.265
Hemorrhage 1.3 (0.3–6.1) 0.733 1.8 (0.2–17.4) 0.594
History of seizure before stroke 4.1 (0.4–37.6) 0.216 n/a
Acute seizure (any) 11.5 (1.4–93.1) 0.022
No acute seizure Reference 0.001b
Single acute seizure 6.0 (0.3–104.8) 0.229
2–10 acute seizures 7.7 (0.8–72.3) 0.074
>10 acute seizures 30.9 (3.0–316.7) 0.003
aNon-neonates. bTest for trend across ordinal categories. OR, odds ratio; n/a, odds ratios not applicable because no epilepsy outcomes;
MCA, middle cerebral artery; ACA, anterior cerebral artery; PCA, posterior cerebral artery; Reference, reference group for comparison of
the other categorical variables
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SUPPORTING INFORMATION
The following additional material may be found online:
Appendix S1: Seizures in Pediatric Stroke (SIPS) sites and
investigators.
Figure S1: Predicted probabilities of an acute seizure (≤7d)
after childhood arterial ischemic stroke in a model excluding
patients who were neonates (birth–28d) at the time of the stroke.
Table SI: Seizure severity among 11 children with epilepsy
1 year after pediatric stroke
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